Cristine Alves da Costa0000-0002-7777-005X
Cristine Alves da Costa graduated in pharmacy-biochemistry from the Faculty of Pharmaceutical Sciences, University Estadual Paulista Julio de Mesquita Filho, Sao Paulo, SP, Brazil, in 1987. She has obtained an M.S. degree in pharmacology from the Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil, in 1991 and a Ph.D. degree in toxicology from the Faculty of Pharmaceutical Sciences, University of Sao Paulo, SP, Brazil, in 1997. From 1998 to 2003, she worked as a Postdoctoral Fellow at the Laboratory of Dr. F. Checler at the Institute of Pharmacology Moleculaire et Cellulaire in France, where she was implicated in studies aiming to clarify the mechanisms of neurodegeneration in Alzheimer’s disease. In 2004, she has got a permanent position as a Senior Research Associate INSERM. In 2009, she was promoted to the grade of the Director of Research INSERM. Actually, she is in charge of a team of 5 people that work in the study of the implication of Parkinson’s disease-associated proteins in the origin of the specific dopaminergic cell death observed in the pathology. She is a Member of the American and French Neuroscience Foundations, an Editor Board Member of several online journals like Clinical Medicine: Geriatrics and Current Neuropharmacology, and a Peer Reviewer to Journal of Neurochemistry, Brain Research, Biochemistry, The Journal of Biological Chemistry, Trends in Molecular Medicine, Neurobiology of disease, and The Journal of Cell Biology. Her research interests include Parkinson’s and Alzheimer’s diseases, molecular and cell biology, apoptosis, and p53. She is also interested in the interplay between these two pathologies via common molecular denominators and the link between neurodegenerative disorders and human brain cancer.
Biography Updated on 18 July 2013